Author

Bhupender Singh

ORCID 0000-0003-1654-5382Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Bhupender Singh1 paper · Biotecnika Info Labs Pvt Ltd

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:protein structure· 1

Frequent Co-Authors

Deepti Subray Bhat· 1 shared Girija Deevi· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

2 top collaborators · 0 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Deepti Subray Bhat

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintNov 1, 2026

Computational Repurposing of FDA Approved Drugs Against Cyclin Dependent Kinase (CDK2)

Girija Deevi, Bhupender Singh

The paper identifies FDA-approved drugs with potential binding activity against CDK2 using computational methods and selects Carteolol as a candidate.

DOI 10.64898/2026.10.27.762194

humanprotein structure

𝕏 PostBluesky

BioinformaticsbioRxivPreprintOct 26, 2026

Pathway-Based Analysis of Essential Metabolic Enzymes as Drug Targets

Deepti Subray Bhat, Bhupender Singh

This study identifies PabB as a potential drug target for tuberculosis by pathway analysis and screens FDA-approved drugs for repurposing using molecular docking.

DOI 10.64898/2026.10.21.754949

humanstatistical model

𝕏 PostBluesky